title: Immunohistochemical determination of EGFR-tyrosine kinase inhibition in clinical samples.
authors.affiliation: Department of Surgery, University of Texas Health Science Center, San Antonio, TX, USA.
authors.forename: Shazli N
authors.initials: SN
authors.lastname: Malik
authors.forename: Roble G
authors.initials: RG
authors.lastname: Bedolla
authors.forename: Manuel
authors.initials: M
authors.lastname: Hidalgo
authors.forename: Michael G
authors.initials: MG
authors.lastname: Brattain
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Kreisberg
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001706:Biopsy; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006416:Hematoxylin; D006801:Humans; D007124:Immunoenzyme Techniques; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology; D016612:Paraffin Embedding; D010766:Phosphorylation / Q000187:drug effects; D011499:Protein Processing, Post-Translational / Q000187:drug effects*; D013048:Specimen Handling; D013194:Staining and Labeling
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D066246:ErbB Receptors; D006416:Hematoxylin